Applied Genetic Technologies (NASDAQ: AGTC) reported Q2 EPS of $0.11, $0.09 better than the analyst estimate of $0.02, may not compare. Revenue for the quarter came in at $10.9 million versus the consensus estimate of $11.1 million.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.